Important industry updates and company news

TransCelerate Biopharma Inc. released a free training on Risk-Based-Monitoring

  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 31.Jul.2014

Since 1996 ICH-GCP has proven to regulators considerable advances in technology. Monitoring and identifying risk has justified all efforts to accomplish safety and compliance of clinical trials, which makes it both beneficial- pharma industry and patients.
Looking at the future of the clinical research world, TransCelerate Biopharma Inc., an independent non-profit organization focused on accelerating the development of new medicines and solving fundamental issues pharmaceutical companies face in bringing new therapeutics to market, believes that their Risk-Based Monitoring (RBM) methodology will have significant impact on clinical trial site monitoring efficiencies. They have just submitted a second update on their manual and their are back to us with a brand new Risk-Based-Monitoring training. You can find it online and it is completely free:

Risk-Based-Monitoring Training

By creating the Better Industry Initiative, we at Astra Nova Training are also trying to ease the industry and all professionals by allowing them to see free training resources, that will answer them many questions about regulations and compliance. We will be glad to always update you on new tendencies and updates that are essential for your business and career, so please join us on our the free training section on our website or follow us here:


Join our 15,420 Users!
Get FREE advice and suggestions on how to improve your medical career with our regular email newsletter.
Sign up NOW
Partners and Clients

Copyright © 2020, AstraNova Ltd. All Rights Reserved.